About Arecor
Arecor is a company based in Cambridge (United Kingdom) founded in 2007.. Arecor has raised $16.27 million across 5 funding rounds from investors including Gov.uk, Downing and Calculus Capital. Arecor has completed 1 acquisition, including Tetris Pharma. Arecor offers products and services including Arestat Technology and Enhanced Medicines. Arecor operates in a competitive market with competitors including Ensysce, Oxular, EryDel, PharmaJet and Splice Bio, among others.
- Headquarter Cambridge, United Kingdom
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Arecor Therapeutics Plc
-
Annual Revenue
$6.33 M (USD)10.5as on Dec 31, 2024
-
Net Profit
$-12.83 M (USD)-19.66as on Dec 31, 2024
-
EBITDA
$-8.83 M (USD)27.18as on Dec 31, 2024
-
Total Equity Funding
$16.27 M (USD)
in 5 rounds
-
Latest Funding Round
$8.26 M (USD), Series B
Jul 24, 2024
-
Investors
Gov.uk
& 4 more
-
Employee Count
Employee Count
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Arecor
Arecor is a publicly listed company on the LSE with ticker symbol AREC in UK, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Arecor
Arecor offers a comprehensive portfolio of products and services, including Arestat Technology and Enhanced Medicines. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for developing enhanced medicines for diabetes treatments.
Medicines targeting diabetes and obesity management through partnerships.
Unlock access to complete
Unlock access to complete
Funding Insights of Arecor
Arecor has successfully raised a total of $16.27M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $8.26 million completed in July 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series B — $8.3M
-
First Round
First Round
(01 Jan 2008)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2024 | Amount | Series B - Arecor | Valuation |
investors |
|
| Mar, 2021 | Amount | Grant - Arecor | Valuation |
investors |
|
| Sep, 2018 | Amount | Series A - Arecor | Valuation | Albion Capital Group , Calculus Capital |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Arecor
Arecor has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Gov.uk, Downing and Calculus Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are managed by Albion Capital.
|
Founded Year | Domain | Location | |
|
UK venture capital investments are managed by Calculus Capital.
|
Founded Year | Domain | Location | |
|
Inheritance tax relief, funds, and bonds are provided across sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Arecor
Arecor has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Tetris Pharma. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Marketing services for healthcare products are provided by Tetris Pharma.
|
2020 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Arecor
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Arecor Comparisons
Competitors of Arecor
Arecor operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ensysce, Oxular, EryDel, PharmaJet and Splice Bio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Drug delivery solutions via single-walled carbon nanotubes are offered.
|
|
| domain | founded_year | HQ Location |
Drug delivery platforms and therapeutics for ophthalmology are developed.
|
|
| domain | founded_year | HQ Location |
Erythrocyte encapsulation systems for drug delivery are developed.
|
|
| domain | founded_year | HQ Location |
Provider of needle-free injection technology
|
|
| domain | founded_year | HQ Location |
Provider of a proprietary platform for gene therapy
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Arecor
Frequently Asked Questions about Arecor
When was Arecor founded?
Arecor was founded in 2007 and raised its 1st funding round 1 year after it was founded.
Where is Arecor located?
Arecor is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.
Is Arecor a funded company?
Arecor is a funded company, having raised a total of $16.27M across 5 funding rounds to date. The company's 1st funding round was a Series A of $7.75M, raised on Jan 01, 2008.
What is the annual revenue of Arecor?
Annual revenue of Arecor is $6.33M as on Dec 31, 2024.
What does Arecor do?
Arecor was founded in 2007 in Cambridge, United Kingdom, within the biotechnology sector. Stabilization technologies are utilized to formulate proteins and vaccines as stable aqueous or dry preparations, suitable for high concentrations or ionizing radiation exposure. The Arestat platform is integrated into existing manufacturing processes without covalent modifications to biologics, employing only GRAS excipients approved by regulatory authorities. Operations focus on enhancing drug delivery formulations.
Who are the top competitors of Arecor?
Arecor's top competitors include Oxular, PharmaJet and Splice Bio.
What products or services does Arecor offer?
Arecor offers Arestat Technology and Enhanced Medicines.
Is Arecor publicly traded?
Yes, Arecor is publicly traded on LSE under the ticker symbol AREC.
How many acquisitions has Arecor made?
Arecor has made 1 acquisition, including Tetris Pharma.
Who are Arecor's investors?
Arecor has 5 investors. Key investors include Gov.uk, Downing, Calculus Capital, Albion Capital, and Seneca Growth Capital.
What is Arecor's ticker symbol?
The ticker symbol of Arecor is AREC on LSE.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.